Trials / Withdrawn
WithdrawnNCT05031481
Efficacy and Safety of Different Doses of Venus Association in Patients With Vulvovaginal Candidiasis.
National, Multicenter, Randomized, Double-blind, Phase II Clinical Trial to Evaluate the Efficacy and Safety of Different Doses of Venus Association in Patients With Vulvovaginal Candidiasis
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- EMS · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of different doses of Venus association in the treatment of vulvovaginal candidiasis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Venus 20 + 0,064 | Venus vaginal cream 20 + 0,064, single-dose. |
| DRUG | Venus 20 + 1 | Venus vaginal cream 20 + 1, single-dose. |
| DRUG | Venus 20 + 4 | Venus vaginal cream 20 + 4, single-dose. |
| DRUG | Butoconazole nitrate | Butoconazole nitrate vaginal cream, 100 mg single-dose. |
Timeline
- Start date
- 2022-07-01
- Primary completion
- 2023-12-01
- Completion
- 2024-03-01
- First posted
- 2021-09-02
- Last updated
- 2022-08-10
Source: ClinicalTrials.gov record NCT05031481. Inclusion in this directory is not an endorsement.